glp-1 gastroparesis legal team in kentucky law office GLP-1 medications are now at the center of growing lawsuits across the United States. The lawsuits allege semaglutide gastrointestinal obstruction lawyer in

Most of the excitement around BPC-157 peptide therapy comes from preclinical research and mechanistic studies

Medical records should also contain the treatment plan, dose of drug, time of infusion and reaction of the patient to treatment

Landmark Research: The First Clinical Evidence in Mast Cell Disorders One of the most groundbreaking developments in this field comes from a landmark clinical study published in July 2025 in The American Journal of the Medical Sciences

The differences between data from animals and humans may be due to three things: (1) the very high-dose of EGCG used in the animal model compared to the single, relatively small dose found in one cup of tea